Shanghai Asclepius Meditec Inc. Report issue

Academic/Hospital Phase 2
Founded: Taipei Taiwan

Organization Overview

First Clinical Trial
2019
NCT03940820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Asclepius Technology Company Group (Suzhou) Co., Ltd. | Shanghai Asclepius Meditec Inc.